newsfilter
← Latest News
FDA Approved Drugs·

Approval of Blujepa, Nda #218230 (Efficacy)

Approval Date: 12/11/2025; Drug Name: Blujepa, Nda #218230; Active Ingredients: GEPOTIDACIN MESYLATE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 218230

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE